Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000590444 | SCV000210949 | uncertain significance | not provided | 2024-06-11 | criteria provided, single submitter | clinical testing | Observed in several individuals with melanoma, pancreatic cancer, or other cancers (PMID: 16234564, 17255954, 17218939, 21150883, 25787093, 26225579, 25479140, 26104880, 25980754, 26681309, 28726808, 34326862); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported using an alternate transcript of the gene; Also known as p.(Ala162Thr); This variant is associated with the following publications: (PMID: 25064638, 25980754, 30709382, 30039340, 16234564, 21150883, 26104880, 17218939, 12538475, 25787093, 26225579, 17255954, 28726808, 29415044, 27621404, 26681309, 19690981, 25780468, 27882345, 25479140, 16896043, 29641532, 11687599, 8710906, 16818274, 12532425, 27756164, 37322831, 28765326, 34326862, 27960642) |
Ambry Genetics | RCV000160416 | SCV000214026 | uncertain significance | Hereditary cancer-predisposing syndrome | 2014-06-10 | criteria provided, single submitter | clinical testing | Insufficient or inconclusive evidence |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000212401 | SCV000695342 | likely benign | not specified | 2020-09-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000590444 | SCV000805824 | uncertain significance | not provided | 2019-11-20 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000212401 | SCV000888053 | benign | not specified | 2021-06-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000160416 | SCV000902687 | likely benign | Hereditary cancer-predisposing syndrome | 2016-05-19 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988150 | SCV001137762 | benign | Melanoma-pancreatic cancer syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001050185 | SCV001214281 | likely benign | Familial melanoma | 2022-11-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000590444 | SCV002498020 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | CDKN2A: BP4 |
Center for Genomic Medicine, |
RCV000212401 | SCV002550353 | uncertain significance | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Baylor- |
RCV002467577 | SCV002764253 | uncertain significance | Maffucci syndrome | criteria provided, single submitter | research | ||
Diagnostic Laboratory, |
RCV000590444 | SCV001742045 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000590444 | SCV001807708 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000590444 | SCV001966469 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000590444 | SCV002037434 | likely benign | not provided | no assertion criteria provided | clinical testing |